Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-096760
Filing Date
2025-07-18
Accepted
2025-07-18 08:00:16
Documents
18
Period of Report
2025-07-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A itrm-20250718.htm   iXBRL PRE 14A 1948616
2 GRAPHIC img249205814_0.jpg GRAPHIC 21045
3 GRAPHIC img249205814_1.jpg GRAPHIC 317341
4 GRAPHIC img249205814_2.jpg GRAPHIC 342984
5 GRAPHIC img249205814_3.jpg GRAPHIC 579155
6 GRAPHIC img249205814_4.jpg GRAPHIC 436150
  Complete submission text file 0000950170-25-096760.txt   6912952

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20250718.xsd EX-101.SCH 14617
20 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20250718_htm.xml XML 266745
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38503 | Film No.: 251132634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)